IRIDEX Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRIX research report →
Companywww.iridex.com
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders.
- CEO
- Patrick Mercer
- IPO
- 1996
- Employees
- 93
- HQ
- Mountain View, CA, US
Price Chart
Valuation
- Market Cap
- $17.40M
- P/E
- -5.29
- P/S
- 0.33
- P/B
- 3.66
- EV/EBITDA
- -7.76
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.12%
- Op Margin
- -5.12%
- Net Margin
- -6.23%
- ROE
- -64.23%
- ROIC
- -16.95%
Growth & Income
- Revenue
- $52.67M · 8.23%
- Net Income
- $-4,437,000 · 50.20%
- EPS
- $-0.26 · 51.85%
- Op Income
- $-2,571,000
- FCF YoY
- 69.06%
Performance & Tape
- 52W High
- $1.65
- 52W Low
- $0.87
- 50D MA
- $1.11
- 200D MA
- $1.18
- Beta
- 0.65
- Avg Volume
- 254.87K
Get TickerSpark's AI analysis on IRIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 1, 26 | Novel Inspiration International Co., Ltd. | other | 87,949 |
| Mar 6, 26 | Dizon Romeo R | buy | 1,110 |
| Feb 17, 26 | Dizon Romeo R | buy | 1,200 |
| Feb 17, 26 | Dizon Romeo R | buy | 1,000 |
| Feb 12, 26 | Dizon Romeo R | buy | 1,500 |
| Feb 10, 26 | Dizon Romeo R | buy | 1,000 |
| Feb 3, 26 | Dizon Romeo R | buy | 2,500 |
| Jan 29, 26 | Dizon Romeo R | buy | 1,101 |
| Jan 28, 26 | Dizon Romeo R | buy | 1,300 |
| Jan 27, 26 | Dizon Romeo R | buy | 3,385 |
Our IRIX Coverage
We haven't published any research on IRIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IRIX Report →